Extensive Use of Interventional Therapies Improves Survival in Unresectable or Recurrent Intrahepatic Cholangiocarcinoma

Por Seidensticker, Ricarda, Seidensticker, Max, Doegen, Kathleen, Mohnike, Konrad, Schütte, Kerstin, Stübs, Patrick, Kettner, Erika, Pech, Maciej, Amthauer, Holger, Ricke, Jens
Publicado no Gastroenterol Res Pract (2016)

Capecitabine and bevacizumab for non-resectable metastatic colorectal cancer patients: final results from phase II AIO KRK 0105 trial

Por Stein, Alexander, Kretzschmar, Albrecht, Behringer, Dirk, Wolff, Thomas, Zimber, Joachim, Hegewisch-Becker, Susanna, Kettner, Erika, Pflüger, Karl-Heinz, Kirsch, Andreas, Arnold, Dirk
Publicado em 2013

Extended RAS analysis and correlation with overall survival in advanced pancreatic cancer

Por Haas, Michael, Ormanns, Steffen, Baechmann, Sibylle, Remold, Anna, Kruger, Stephan, Westphalen, Christoph B, Siveke, Jens T, Wenzel, Patrick, Schlitter, Anna Melissa, Esposito, Irene, Quietzsch, Detlef, Clemens, Michael R, Kettner, Erika, Laubender, Ruediger P, Jung, Andreas, Kirchner, Thomas, Boeck, Stefan, Heinemann, Volker
Publicado no Br J Cancer (2017)